Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.18
    +47.10 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,121.61
    +7.26 (+0.34%)
     
  • Crude Oil

    82.97
    +1.62 (+1.99%)
     
  • Gold

    2,241.00
    +28.30 (+1.28%)
     
  • Silver

    24.99
    +0.23 (+0.94%)
     
  • EUR/USD

    1.0791
    -0.0039 (-0.36%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • GBP/USD

    1.2621
    -0.0017 (-0.14%)
     
  • USD/JPY

    151.3830
    +0.1370 (+0.09%)
     
  • Bitcoin USD

    70,852.78
    +2,216.76 (+3.23%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,168.07
    -594.66 (-1.46%)
     

Tilray (TLRY) in Focus: Stock Moves 9.6% Higher

Tilray, Inc. TLRY was a big mover last session, as the company saw its shares rise nearly 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $2.47–$9.10 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen four negative estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved lower over the same time period, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Tilray currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Tilray, Inc. Price

Tilray, Inc. Price
Tilray, Inc. Price

Tilray, Inc. price | Tilray, Inc. Quote


A better-ranked stock in the Medical sector is Esperion Therapeutics, Inc. ESPR, which currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Esperion Therapeutics, Inc. (ESPR) : Free Stock Analysis Report
 
Tilray, Inc. (TLRY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement